Dihydrotachysterol Capsules
» Dihydrotachysterol Capsules contain a solution of Dihydrotachysterol in a suitable vegetable oil. Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C28H46O.
Packaging and storage— Preserve in well-closed, light-resistant containers.
USP Reference standards 11—
USP Dihydrotachysterol RS Click to View Structure
Identification—
A: Cut open 1 Capsule, and remove the contents: the Capsule contents respond to Identification test A under Dihydrotachysterol Oral Solution.
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that of the Standard preparation obtained as directed in the Assay.
Uniformity of dosage units 905: meet the requirements.
Assay—
Mobile phase , Standard preparation, System suitability preparation, and Chromatographic system—Prepare as directed in the Assay under Dihydrotachysterol.
Assay preparation— Combine the contents of not less than 20 Capsules. Transfer an accurately weighed quantity of Capsule contents, equivalent to about 500 µg of dihydrotachysterol, to a 50-mL volumetric flask, dissolve in 25 mL of Mobile phase, and mix. Dilute with Mobile phase to volume, and mix.
Procedure— Proceed as directed for Procedure in the Assay under Dihydrotachysterol. Calculate the quantity, in µg, of C28H46O in the portion of Capsules taken by the formula:
50C(rU / rS)
in which C is the concentration, in µg per mL, of USP Dihydrotachysterol RS in the Standard preparation, and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Elena Gonikberg, Ph.D.
Principal Scientific Liaison
1-301-816-8251		 (SM32010) Monographs - Small Molecules 3
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 2911